- Global Pharma News & Resources

Press Releases

Date Title Company
18-Aug-2022 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
18-Aug-2022 Contact-Free Sleep Monitoring Systems Market Current and Future Demand, Analysis, Growth and Forecast By 2027 MARKITWIRED
18-Aug-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
18-Aug-2022 CureVac Announces Financial Results for the Second Quarter and First Half of 2022 and Provides Business Update CureVac
18-Aug-2022 CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate CureVac
18-Aug-2022 Spatial Mass Spectrometry Market Share, Regional Overview and SWOT Analysis till 2032 MARKITWIRED
18-Aug-2022 Hemostatic Gels Market Trends, Demand Growth Revenue Analysis Report to 2032 MARKITWIRED
18-Aug-2022 Clinical Information System Market Overview, High Growth Opportunities, Segmentation, Trends By 2022-2032 MARKITWIRED
18-Aug-2022 Ultrasound-Guided Breast Biopsy Market Segmentation by Revenue, Present & Future Scenario To 2032 MARKITWIRED
18-Aug-2022 Legionnaire Disease Testing Market Size, Strategies and Opportunities Forecast 2022-2032 MARKITWIRED
18-Aug-2022 Dental Floss Market Application, Growth, Demand, Status, and Forecast from 2022 to 2032 MARKITWIRED
18-Aug-2022 Paediatric Spasticity Treatment Market Status, Growth Opportunity, Size, Trends, Key Industry Outlook 2022-2032 MARKITWIRED
18-Aug-2022 What’s the secret of the 15% of Brits who’ve never had Covid? London Medical Laboratory
18-Aug-2022 InnoScot Health collaboration provides almost complete barrier to virus transmission during CPR InnoScot Health
18-Aug-2022 Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA) Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
18-Aug-2022 ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing ProBioGen
18-Aug-2022 NICE Recommends RINVOQ®▼(upadacitinib) As A Treatment Option For Active Ankylosing Spondylitis (AS) In Adults AbbVie
18-Aug-2022 Sanofi provides update on amcenestrant clinical development program Sanofi
18-Aug-2022 Orgenesis Achieves Revenue of USD 7.2 Million for the Second Quarter of 2022 Orgenesis
18-Aug-2022 Inizio strengthens leadership team with two key appointments Inizio